BILL ANALYSIS

S3674

BEARISH

SCAM Act

S3674 (SCAM Act) carries an AI-assessed market impact score of 4/10 with a bearish outlook for investors. This legislation directly affects Humana ($HUM), $W and $FNF. The primary sectors impacted are Technology, Finance and Healthcare. View the full bill text on Congress.gov.

4/10

Impact Score

bearish

Market Sentiment

Affected Stocks

Sectors Impacted

Key Takeaways for Investors

Zero funding authorized—no direct federal spending impact

Procedural step only; bill is on Senate calendar but not scheduled for floor vote

No publicly traded companies directly named; any impact is indirect and speculative

How S3674 Affects the Market

This bill has minimal near-term market implications. No publicly traded companies are directly affected by the expansion of civil denaturalization grounds. The most plausible secondary effects—increased legal services demand and marginal compliance costs for government program administrators—are too diffuse and uncertain to drive material changes in stock prices. Investors should not adjust positions based on this legislative development.

Bill Details

Metric	Value
Bill Number	S3674
Impact Score	4/10Certainty: Floor action · Financial Magnitude: No explicit funding identified · Strategic Weight: AI qualitative assessment: 2/10 · Market Penetration: 3 companies directly affected across 3 sectors
Market Sentiment	bearish
Event Date	January 26, 2026
Affected Sectors	Technology, Finance, Healthcare
Affected Stocks	Humana ($HUM), $W, $FNF
Source	View on Congress.gov →

Summary

The SCAM Act (S.3674) expands civil denaturalization grounds for fraud against governmental programs, terrorist affiliation, and certain crimes. It has advanced to the Senate Legislative Calendar but authorizes zero new funding. The bill's impact is procedural and indirect, with no near-term direct market implications for publicly traded companies.

Full AI Market Analysis

The SCAM Act (S.3674), introduced by Sen. Schmitt (R-MO) and with 10 cosponsors, has advanced to the Senate Legislative Calendar after being read twice in January 2026—the only action occurring in the 119th Congress. The bill clarifies and expands existing legal frameworks for civil denaturalization, but does not authorize or appropriate any new funding. The money trail is absent: this is a purely regulatory and legal bill with no spending authorization. It does not create new grants, contracts, or tax benefits for any private sector entity. Any market impact would stem entirely from secondary behavioral effects of enhanced enforcement. Structural winners are minimal. Legal services firms specializing in immigration could see increased demand, but no publicly traded pure-play exists with meaningful exposure. Structural losers are indirectly affected: government program participants (SNAP, Medicare Advantage, federal housing) may face increased scrutiny, potentially reducing utilization. Companies with exposure to these programs—Walmart (SNAP), Humana (Medicare Advantage), Fidelity National Financial (VA/FHA mortgages)—face marginal compliance and revenue risks, but these are highly speculative at this early legislative stage. No real market data was provided for analysis. The competitive landscape remains unchanged by this bill. Timeline: The bill is on the Senate Legislative Calendar (Calendar No. 301) but has not been scheduled for floor debate. A companion bill (HR7156) exists in the House but remains in committee. Passage in the 119th Congress is uncertain given the procedural distance from final passage.